Abstract
Colorectal cancer (CRC) develops over a period of years through a defined progression from a single aberrant crypt to a benign adenoma and ultimately to an invasive malignancy. These phenotypic steps parallel a series of underlying changes at the DNA level. Many of the critical tumor suppressor loci have been identified through cytogenetic or genetic linkage studies of inherited disorders that predispose affected family members to the development of benign or malignant lesions in the colorectal epithelium. Inactivating mutations in the APC gene not only were first identified in the germline of individuals with familial adenomatous polyposis coli but also are present in most sporadic CRCs. Germline mutations in MSH2, MLH1, MSH6, or PMS2 predispose individuals with Lynch syndrome to CRCs with DNA mismatch repair defects; these genes can be mutated or silenced in sporadic CRCs as well. Other inherited mutations are responsible for benign colorectal lesions that rarely progress to malignancy, including those found in the SMAD4, BMPR1A, and PTEN genes. Sporadic changes in these genes are found in malignant rather than premalignant lesions, suggesting that these mutations promote rather than initiate tumorigenesis. Genetic analysis of CRCs will permit stratification for improved prognosis and treatment.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Aaltonen LA et al (1993) Clues to the pathogenesis of familial colorectal cancer. Science 260(5109):812–816
Abdul Khalek FJ, Gallicano GI, Mishra L (2010) Colon cancer stem cells. Gastrointest Cancer Res (suppl 1):S16–S23
Akiyama Y et al (1997) Transforming growth factor beta type II receptor gene mutations in adenomas from hereditary nonpolyposis colorectal cancer. Gastroenterology 112(1):33–39
Alexandrow MG, Moses HL (1995) Transforming growth factor beta and cell cycle regulation. Cancer Res 55(7):1452–1457
Al-Tassan N et al (2002) Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors. Nat Genet 30(2):227–232
Amos CI et al (1993) Peutz-Jeghers syndrome. In: Pagon RA et al (eds) Gene reviews. University of Washington, Seattle, WA
Aretz S et al (2006) MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. Int J Cancer 119(4):807–814
Aretz S et al (2007) High proportion of large genomic deletions and a genotype phenotype update in 80 unrelated families with juvenile polyposis syndrome. J Med Genet 44(11):702–709
Avizienyte E et al (1999) LKB1 somatic mutations in sporadic tumors. Am J Pathol 154(3):677–681
Beck NE et al (1997) Genetic testing is important in families with a history suggestive of hereditary non-polyposis colorectal cancer even if the Amsterdam criteria are not fulfilled. Br J Surg 84(2):233–237
Behrens J et al (1998) Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 280(5363):596–599
Boardman LA et al (1998) Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann Intern Med 128(11):896–899
Bodmer WF et al (1987) Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 328(6131):614–616
Boland CR, Goel A (2010) Microsatellite instability in colorectal cancer. Gastroenterology 138(6):2073–2087 e3
Brosens LA et al (2007) Risk of colorectal cancer in juvenile polyposis. Gut 56(7):965–967
Brownstein MH, Wolf M, Bikowski JB (1978) Cowden’s disease: a cutaneous marker of breast cancer. Cancer 41(6):2393–2398
Calin GA et al (2000) Genetic progression in microsatellite instability high (MSI-H) colon cancers correlates with clinico-pathological parameters: a study of the TGRbetaRII, BAX, hMSH3, hMSH6, IGFIIR and BLM genes. Int J Cancer 89(3):230–235
Carr JC et al (2012) Germline mutations in SMAD4 disrupt bone morphogenetic protein signaling. J Surg Res 174(2):211–214
Chan TL et al (2006) Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer. Nat Genet 38(10):1178–1183
Cohen MM Jr (1990) Bannayan-Riley-Ruvalcaba syndrome: renaming three formerly recognized syndromes as one etiologic entity. Am J Med Genet 35(2):291–292
Cripps WH (1882) Two cases of disseminated polypus of the rectum. Trans Pathol Soc Lond 33:165–168
Dai J et al (2005) Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism. Cancer Res 65(18):8274–8285
Datta K et al (1996) Akt is a direct target of the phosphatidylinositol 3-kinase. Activation by growth factors, v-src and v-Ha-ras, in Sf9 and mammalian cells. J Biol Chem 271(48):30835–30839
Diamond M (1939) Adenoma of the rectum in children: report of a case in a thirty-month-old girl. Am J Dis Child 57:360–367
Dicuonzo G et al (2001) Colorectal carcinomas and PTEN/MMAC1 gene mutations. Clin Cancer Res 7(12):4049–4053
Dolwani S et al (2003) MYH polyposis: a new autosomal recessive form of familial adenomatous polyposis due to defective base excision repair—reappraisal of genetic risk and family management. Gastroenterology 124(suppl 1):A46–A198
Douglas JA et al (2005) History and molecular genetics of Lynch syndrome in family G: a century later. JAMA 294(17):2195–2202
Dukes C (1930) The hereditary factor in polyposis intestini, or multiple adenomata. Cancer Rev Br 5:241–256
Duncan BK, Miller JH (1980) Mutagenic deamination of cytosine residues in DNA. Nature 287(5782):560–561
Dutrillaux B (1988) [Recent data on the cytogenetics of colorectal adenocarcinoma]. Bull Cancer 75(6):509–516
Eng C, Ji H (1998) Molecular classification of the inherited hamartoma polyposis syndromes: clearing the muddied waters. Am J Hum Genet 62(5):1020–1022
Fearon ER et al (1990) Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247(4938):49–56
Fevr T et al (2007) Wnt/beta-catenin is essential for intestinal homeostasis and maintenance of intestinal stem cells. Mol Cell Biol 27(21):7551–7559
Fishel R et al (1993) The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75(5):1027–1038
Fuchs CS et al (1994) A prospective study of family history and the risk of colorectal cancer. N Engl J Med 331(25):1669–1674
Galiatsatos P, Foulkes WD (2006) Familial adenomatous polyposis. Am J Gastroenterol 101(2):385–398
Gardner E (1951) A genetic and clinical study of intestinal polyposis, a predisposing factor for carcinoma of the colon and rectum. Am J Hum Genet 3:167–176
Gardner EJ, Plenk HP (1952) Hereditary pattern for multiple osteomas in a family group. Am J Hum Genet 4(1):31–36
Gardner EJ, Richards RC (1953) Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis. Am J Hum Genet 5(2):139–147
Gardner EJ, Stephens FE (1950) Cancer of the lower digestive tract in one family group. Am J Hum Genet 2(1):41–48
Gazzoli I et al (2002) A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor. Cancer Res 62(14):3925–3928
Giardiello F (1995) Gastrointestinal polyposis syndromes and hereditary nonpolyposis colorectal cancer. In: Rustigi AK (ed) Gastrointestinal cancers: biology, diagnosis, and therapy. Lippincott-Raven, Philadelphia, pp 367–377
Giardiello FM et al (1987) Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 316(24):1511–1514
Giardiello FM et al (1991) Colorectal neoplasia in juvenile polyposis or juvenile polyps. Arch Dis Child 66(8):971–975
Goel A et al (2007) The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Gastroenterology 132(1):127–138
Groden J et al (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66(3):589–600
Groen EJ et al (2008) Extra-intestinal manifestations of familial adenomatous polyposis. Ann Surg Oncol 15(9):2439–2450
Haggar FA, Boushey RP (2009) Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 22(4):191–197
Half E, Bercovich D, Rozen P (2009) Familial adenomatous polyposis. Orphanet J Rare Dis 4:22
Halford SE et al (2003) Germline mutations but not somatic changes at the MYH locus contribute to the pathogenesis of unselected colorectal cancers. Am J Pathol 162(5):1545–1548
Hamilton SR et al (1995) The molecular basis of Turcot’s syndrome. N Engl J Med 332(13):839–847
Hawley SA et al (2003) Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2(4):28
He TC et al (1998) Identification of c-MYC as a target of the APC pathway. Science 281(5382):1509–1512
Hemminki A et al (1994) Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer. Nat Genet 8(4):405–410
Hemminki A et al (1998) A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391(6663):184–187
Henderson BR (2000) Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover. Nat Cell Biol 2(9):653–660
Hendriks YM et al (2004) Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology 127(1):17–25
Herrera L et al (1986) Gardner syndrome in a man with an interstitial deletion of 5q. Am J Med Genet 25(3):473–476
Holliday R (1964) A mechanism for gene conversion in fungi. Genet Res 5:282–304
Howe JR et al (1998) Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 280(5366):1086–1088
Howe JR et al (2001) Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet 28(2):184–187
Howe JR et al (2004) The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations. J Med Genet 41(7):484–491
Huber MA, Kraut N, Beug H (2005) Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17(5):548–558
Hulsken J, Birchmeier W, Behrens J (1994) E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. J Cell Biol 127(6 Pt 2):2061–2069
Ichii S et al (1993) Detailed analysis of genetic alterations in colorectal tumors from patients with and without familial adenomatous polyposis (FAP). Oncogene 8(9):2399–2405
Iino H et al (2000) DNA microsatellite instability and mismatch repair protein loss in adenomas presenting in hereditary non-polyposis colorectal cancer. Gut 47(1):37–42
Ionov Y et al (1993) Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363(6429):558–561
Jager AC et al (1997) Reduced frequency of extracolonic cancers in hereditary nonpolyposis colorectal cancer families with monoallelic hMLH1 expression. Am J Hum Genet 61(1):129–138
Jass JR (2006) Hereditary non-polyposis colorectal cancer: the rise and fall of a confusing term. World J Gastroenterol 12(31):4943–4950
Jeghers H, Mc KV, Katz KH (1949) Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits; a syndrome of diagnostic significance. N Engl J Med 241(26):1031–1036
Jen J et al (1994) Molecular determinants of dysplasia in colorectal lesions. Cancer Res 54(21):5523–5526
Jenne DE et al (1998) Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 18(1):38–43
Jones S et al (2002) Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C→T:A mutations. Hum Mol Genet 11(23):2961–2967
Joslyn G et al (1991) Identification of deletion mutations and three new genes at the familial polyposis locus. Cell 66(3):601–613
Kennedy SG et al (1997) The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev 11(6):701–713
Kim JC et al (2008) Individual tumorigenesis pathways of sporadic colorectal adenocarcinomas are associated with the biological behavior of tumors. Cancer Sci 99(7):1348–1354
Kinzler KW, Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87(2):159–170
Kinzler KW, Vogelstein B (1998) Landscaping the cancer terrain. Science 280(5366):1036–1037
Kinzler KW et al (1991) Identification of FAP locus genes from chromosome 5q21. Science 253(5020):661–665
Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 68(4):820–823
Korinek V et al (1997) Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC−/− colon carcinoma. Science 275(5307):1784–1787
Kosinski C et al (2007) Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors. Proc Natl Acad Sci U S A 104(39):15418–15423
Lanspa SJ et al (1990) Colorectal adenomas in the Lynch syndromes. Results of a colonoscopy screening program. Gastroenterology 98(5 Pt 1):1117–1122
Leppert M et al (1987) The gene for familial polyposis coli maps to the long arm of chromosome 5. Science 238(4832):1411–1413
Levy DB et al (1994) Inactivation of both APC alleles in human and mouse tumors. Cancer Res 54(22):5953–5958
Li DM, Sun H (1998) PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc Natl Acad Sci U S A 95(26):15406–15411
Liaw D et al (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16(1):64–67
Lindor NM et al (2005) Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 293(16):1979–1985
Lipkin SM et al (2000) MLH3: a DNA mismatch repair gene associated with mammalian microsatellite instability. Nat Genet 24(1):27–35
Liu T et al (2001) The role of hPMS1 and hPMS2 in predisposing to colorectal cancer. Cancer Res 61(21):7798–7802
Liu HX et al (2003) The role of hMLH3 in familial colorectal cancer. Cancer Res 63(8):1894–1899
Llor X et al (2005) Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway. Clin Cancer Res 11(20):7304–7310
Lloyd KM II, Dennis M (1963) Cowden’s disease. A possible new symptom complex with multiple system involvement. Ann Intern Med 58:136–142
Lombardo Y et al (2011) Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice. Gastroenterology 140(1):297–309
Loukola A et al (2000) Germline and somatic mutation analysis of MLH3 in MSI-positive colorectal cancer. Am J Pathol 157(2):347–352
Lu SL et al (1995) Mutations of the transforming growth factor-beta type II receptor gene and genomic instability in hereditary nonpolyposis colorectal cancer. Biochem Biophys Res Commun 216(2):452–457
Lu SL et al (1998) HNPCC associated with germline mutation in the TGF-beta type II receptor gene. Nat Genet 19(1):17–18
Luongo C et al (1994) Loss of Apc+ in intestinal adenomas from Min mice. Cancer Res 54(22):5947–5952
Lynch HT, Krush AJ (1971) Cancer family “G” revisited: 1895–1970. Cancer 27(6):1505–1511
Lynch HT, Lynch J (2000) Lynch syndrome: genetics, natural history, genetic counseling, and prevention. J Clin Oncol 18(21 suppl):19S–31S
Lynch HT et al (1966) Hereditary factors in cancer. Study of two large midwestern kindreds. Arch Intern Med 117(2):206–212
Lynch HT et al (1985) Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II. I. Clinical description of resource). Cancer 56(4):934–938
Lynch HT et al (1993) Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 104(5):1535–1549
Lynch ED et al (1997) Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis. Am J Hum Genet 61(6):1254–1260
Lynch HT et al (2011) Lynch syndrome-associated extracolonic tumors are rare in two extended families with the same EPCAM deletion. Am J Gastroenterol 106(10):1829–1836
Maehama T, Dixon JE (1998) The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273(22):13375–13378
Markowitz SD, Roberts AB (1996) Tumor suppressor activity of the TGF-beta pathway in human cancers. Cytokine Growth Factor Rev 7(1):93–102
Markowitz S et al (1995) Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268(5215):1336–1338
Marsh DJ et al (1997) Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet 16(4):333–334
Marsh DJ et al (1998) Germline PTEN mutations in Cowden syndrome-like families. J Med Genet 35(11):881–885
Marsischky GT et al (1996) Redundancy of Saccharomyces cerevisiae MSH3 and MSH6 in MSH2-dependent mismatch repair. Genes Dev 10(4):407–420
Massague J, Blain SW, Lo RS (2000) TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103(2):295–309
Mehlen P et al (1998) The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature 395(6704):801–804
Menko FH et al (2008) Variable phenotypes associated with 10q23 microdeletions involving the PTEN and BMPR1A genes. Clin Genet 74(2):145–154
Migliore L et al (2011) Genetics, cytogenetics, and epigenetics of colorectal cancer. J Biomed Biotechnol 2011:792362
Miyaki M et al (1997) Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet 17(3):271–272
Miyaki M et al (1999) Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene 18(20):3098–3103
Miyazono K (1999) Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins. Bone 25(1):91–93
Miyoshi Y et al (1992) Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1(4):229–233
Modrich P (1991) Mechanisms and biological effects of mismatch repair. Annu Rev Genet 25:229–253
Morin PJ et al (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275(5307):1787–1790
Munemitsu S et al (1994) The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res 54(14):3676–3681
Munemitsu S et al (1995) Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci U S A 92(7):3046–3050
Nagase H, Nakamura Y (1993) Mutations of the APC (adenomatous polyposis coli) gene. Hum Mutat 2(6):425–434
Naguib A et al (2011) Alterations in PTEN and PIK3CA in colorectal cancers in the EPIC Norfolk study: associations with clinicopathological and dietary factors. BMC Cancer 11:123
Nakajima G et al (2006) Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are associated with chemoresponse to S-1 in colon cancer. Cancer Genomics Proteomics 3(5):317–324
Namiki M et al (1997) A kinase domain-truncated type I receptor blocks bone morphogenetic protein-2-induced signal transduction in C2C12 myoblasts. J Biol Chem 272(35):22046–22052
Natsume T et al (1997) Interaction between soluble type I receptor for bone morphogenetic protein and bone morphogenetic protein-4. J Biol Chem 272(17):11535–11540
Negri FV et al (2010) PTEN status in advanced colorectal cancer treated with cetuximab. Br J Cancer 102(1):162–164
Neufeld KL et al (2000) APC-mediated downregulation of beta-catenin activity involves nuclear sequestration and nuclear export. EMBO Rep 1(6):519–523
Nicolaides NC et al (1994) Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 371(6492):75–80
Nicolaides NC et al (1998) A naturally occurring hPMS2 mutation can confer a dominant negative mutator phenotype. Mol Cell Biol 18(3):1635–1641
Nieminen TT et al (2011) BMPR1A mutations in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency. Gastroenterology 141(1):e23–e26
Nishisho I et al (1991) Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253(5020):665–669
Ohmiya N et al (2001) Germline and somatic mutations in hMSH6 and hMSH3 in gastrointestinal cancers of the microsatellite mutator phenotype. Gene 272(1–2):301–313
Ohtsubo T et al (2000) Identification of human MutY homolog (hMYH) as a repair enzyme for 2-hydroxyadenine in DNA and detection of multiple forms of hMYH located in nuclei and mitochondria. Nucleic Acids Res 28(6):1355–1364
Olschwang S et al (1998) PTEN germ-line mutations in juvenile polyposis coli. Nat Genet 18(1):12–14
Papadopoulos N et al (1994) Mutation of a mutL homolog in hereditary colon cancer. Science 263(5153):1625–1629
Parsons R et al (1995) Mismatch repair deficiency in phenotypically normal human cells. Science 268(5211):738–740
Peltomaki P (2005) Lynch syndrome genes. Fam Cancer 4(3):227–232
Peltomaki P, Vasen HF (1997) Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology 113(4):1146–1158
Peltomaki P et al (1993) Genetic mapping of a locus predisposing to human colorectal cancer. Science 260(5109):810–812
Peutz J (1921) Ned Tijdschr Geneeskd 10:134
Plaschke J et al (2004) Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium. J Clin Oncol 22(22):4486–4494
Powell SM et al (1992) APC mutations occur early during colorectal tumorigenesis. Nature 359(6392):235–237
Qian J et al (2007) Caspase cleavage of the APC tumor suppressor and release of an amino-terminal domain is required for the transcription-independent function of APC in apoptosis. Oncogene 26(33):4872–4876
Ricci-Vitiani L et al (2009) Colon cancer stem cells. J Mol Med (Berl) 87(11):1097–1104
Riegert-Johnson DL et al (2010) Cancer and Lhermitte-Duclos disease are common in cowden syndrome patients. Hered Cancer Clin Pract 8(1):6
Riggins GJ et al (1997) Frequency of Smad gene mutations in human cancers. Cancer Res 57(13):2578–2580
Rosin-Arbesfeld R, Townsley F, Bienz M (2000) The APC tumour suppressor has a nuclear export function. Nature 406(6799):1009–1012
Rothhammer T et al (2005) Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration. Cancer Res 65(2):448–456
Samowitz WS et al (1999) Beta-catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas. Cancer Res 59(7):1442–1444
Sampson JR et al (2003) Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet 362(9377):39–41
Sansal I, Sellers WR (2004) The biology and clinical relevance of the PTEN tumor suppressor pathway. J Clin Oncol 22(14):2954–2963
Satoh S et al (2000) AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 24(3):245–250
Scott RJ et al (2001) Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet 68(1):118–127
Shaw RJ et al (2004) The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci U S A 101(10): 3329–3335
Shtutman M et al (1999) The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A 96(10):5522–5527
Sieber OM et al (2003) Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 348(9):791–799
Slaby O et al (2007) Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 72(5–6):397–402
Slupska MM et al (1999) Functional expression of hMYH, a human homolog of the Escherichia coli MutY protein. J Bacteriol 181(19):6210–6213
Smilow PC, Pryor CA Jr, Swinton NW (1966) Juvenile polyposis coli. A report of three patients in three generations of one family. Dis Colon Rectum 9(4):248–254
Smith KJ et al (1994) Wild-type but not mutant APC associates with the microtubule cytoskeleton. Cancer Res 54(14):3672–3675
Soker S et al (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92(6):735–745
Solomon E et al (1987) Chromosome 5 allele loss in human colorectal carcinomas. Nature 328(6131):616–619
Spirio L et al (1993) Alleles of the APC gene: an attenuated form of familial polyposis. Cell 75(5):951–957
Stambolic V et al (1998) Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95(1):29–39
Steigerwald K et al (2005) The APC tumor suppressor promotes transcription-independent apoptosis in vitro. Mol Cancer Res 3(2):78–89
Streisinger G et al (1966) Frameshift mutations and the genetic code. This paper is dedicated to Professor Theodosius Dobzhansky on the occasion of his 66th birthday. Cold Spring Harb Symp Quant Biol 31:77–84
Stryker SJ et al (1987) Natural history of untreated colonic polyps. Gastroenterology 93(5): 1009–1013
Subramony C et al (1994) Familial juvenile polyposis. Study of a kindred: evolution of polyps and relationship to gastrointestinal carcinoma. Am J Clin Pathol 102(1):91–97
Sun H et al (1999) PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci U S A 96(11):6199–6204
Suter CM, Martin DI, Ward RL (2004) Germline epimutation of MLH1 in individuals with multiple cancers. Nat Genet 36(5):497–501
Takagi Y et al (1998) Somatic alterations of the SMAD-2 gene in human colorectal cancers. Br J Cancer 78(9):1152–1155
Takao M et al (1999) Differential subcellular localization of human MutY homolog (hMYH) and the functional activity of adenine:8-oxoguanine DNA glycosylase. Nucleic Acids Res 27(18):3638–3644
Tan MH et al (2012) Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res 18(2):400–407
ten Dijke P et al (2003) Controlling cell fate by bone morphogenetic protein receptors. Mol Cell Endocrinol 211(1–2):105–113
Tetsu O, McCormick F (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398(6726):422–426
Thawani JP et al (2010) Bone morphogenetic proteins and cancer: review of the literature. Neurosurgery 66(2):233–246; discussion 246
Theriault BL et al (2007) BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells. Carcinogenesis 28(6):1153–1162
Thompson E et al (2004) Hereditary non-polyposis colorectal cancer and the role of hPMS2 and hEXO1 mutations. Clin Genet 65(3):215–225
Tsuchiya R, Fujisawa N (1999) Historical survey of carcinoma of the pancreas. J Hepatobiliary Pancreat Surg 6(2):165–170
Umar A et al (2004) Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96(4):261–268
Valle L et al (2007) Clinicopathologic and pedigree differences in amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status. J Clin Oncol 25(7):781–786
Vasen HF et al (1996) Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 110(4):1020–1027
Vasen HF et al (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116(6):1453–1456
Vogelstein B, Kinzler KW (2004) Cancer genes and the pathways they control. Nat Med 10(8):789–799
Vogelstein B et al (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319(9):525–532
Wall ME, Wani MC (1995) Camptothecin and taxol: discovery to clinic—thirteenth Bruce F. Cain Memorial Award Lecture. Cancer Res 55(4):753–760
Wang ZJ et al (1998) Genetic pathways of colorectal carcinogenesis rarely involve the PTEN and LKB1 genes outside the inherited hamartoma syndromes. Am J Pathol 153(2):363–366
Warthin A (1913) Heredity with reference to carcinoma. Arch Intern Med 12:546–555
Woods A et al (2003) LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 13(22):2004–2008
Wu Y et al (2001) Germline mutations of EXO1 gene in patients with hereditary nonpolyposis colorectal cancer (HNPCC) and atypical HNPCC forms. Gastroenterology 120(7):1580–1587
Yan H et al (2000) Conversion of diploidy to haploidy. Nature 403(6771):723–724
Zhang T et al (2001) Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res 61(24):8664–8667
Zhang H et al (2007) ErbB receptors: from oncogenes to targeted cancer therapies. J Clin Invest 117(8):2051–2058
Zhou XP et al (2001) Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. Am J Hum Genet 69(4):704–711
Zimmerman M (2003) In: Aufderheide A (ed) The scientific study of mummies. Cambridge University Press: Cambridge
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hankey, W., Groden, J. (2013). The Genetics of Colorectal Cancer. In: Haigis, Ph.D., K. (eds) Molecular Pathogenesis of Colorectal Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8412-7_1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8412-7_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8411-0
Online ISBN: 978-1-4614-8412-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)